Sponsor or institution
Clinical trials and research at Swedish Orphan Biovitrum
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Swedish Orphan Biovitrum that are recruiting, at sites in 18 countries (most in Canada (3), France (3), Germany (3)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 18Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pegcetacoplan to prevent recurrence of C3G/IC-MPGN after kidney transplant | Phase 3 | Recife, Pernambuco and 32 other locations | Recruiting | Oct 27, 2026 |
| Pacritinib Effectiveness in Real-world Settings | — | New Haven, Connecticut and 4 other locations | Recruiting | Aug 19, 2026 |
| Pegcetacoplan in real-world C3G and IC-MPGN patients | Phase 4 | Kingswood and 100 other locations | Recruiting | Aug 5, 2026 |
| Assessing the effectiveness of pacritinib for VEXAS syndrome | Phase 2 | Scottsdale, Arizona and 38 other locations | Recruiting | Jan 17, 2025 |
All recruiting trials (4)
-
Pegcetacoplan to prevent recurrence of C3G/IC-MPGN after kidney transplant
This study tests whether giving pegcetacoplan around the time of kidney transplant can delay or prevent recurrent C3 glomerulopathy or primary IC-MPGN in eligible patients.
-
Pacritinib Effectiveness in Real-world Settings
This real-world study will see how pacritinib works for adults with myelofibrosis by looking back at medical records from several centers.
-
Pegcetacoplan in real-world C3G and IC-MPGN patients
This study tests pegcetacoplan's safety and effectiveness in people with C3 glomerulopathy or primary IC-MPGN in real-world practice.
-
Assessing the effectiveness of pacritinib for VEXAS syndrome
This study is testing if the drug pacritinib can help people with VEXAS syndrome manage their symptoms better while reducing their need for steroids.
Quick answers
How many clinical trials run by Swedish Orphan Biovitrum are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in Canada (3 trials), France (3 trials), Germany (3 trials), Italy (3 trials), Spain (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.